Grantham, Mayo, Van Otterloo & Co (GMO)
CVS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s CVS Health CVS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-220,000
Closed -$13.7M – 566
2018
Q1 		$13.7M Buy
+220,000
New +$15.8M 0.08% 132

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CVS Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its CVS Health (CVS) stake by 12% in Q1 2026, selling an estimated $6.65M and leaving 634,846 shares worth $45.6M. The position accounts for 0.12% of the portfolio, ranked #75.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CVS in Q2 2013 and has held it in 41 quarters since. The position peaked at $241M in Q1 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 634,846 shares of CVS Health worth $45.6M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 86,272 CVS Health shares in Q1 2026, an estimated $6.65M.
  • CVS Health made up 0.12% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #75 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CVS Health in Q2 2013 and has held it in 41 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CVS Health position peaked at $241M in Q1 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.